Why is Repligen Corp. ?
- The company has declared positive results for the last 2 consecutive quarters
- INTEREST COVERAGE RATIO(Q) Highest at 841.97
- INVENTORY TURNOVER RATIO(HY) Highest at 2.2 times
- NET SALES(Q) Highest at USD 188.81 MM
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -19.88%, its profits have risen by 143.3% ; the PEG ratio of the company is 0.9
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you buy?
- Overall Portfolio exposure to Repligen Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Repligen Corp. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at 841.97
Highest at 2.2 times
Highest at USD 188.81 MM
Highest at USD 49.09 MM
Fallen by -5.74% (YoY
Highest at 26 %
Highest at USD 15.42 MM
At USD 13.44 MM has Grown at 43.45%
Highest at USD 0.26
Lowest at USD 130.89 MM
Here's what is working for Repligen Corp.
Operating Profit to Interest
Net Sales (USD MM)
Operating Profit (USD MM)
Inventory Turnover Ratio
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Raw Material Cost as a percentage of Sales
Here's what is not working for Repligen Corp.
Operating Cash Flows (USD MM)






